Macular pigment optical density screening photometer MPS II

Now eye care professionals can take a proactive, preventative approach to the growing global problem of age-related macular degeneration (AMD). Measuring macular pigment optical density (MPOD) – a significant and modifiable risk factor for AMD – the MPS II provides results at speeds as fast as 90 seconds per eye. A proactive approach to a global issue Added value for practitioners and patients Age-related macular degeneration (AMD) is a growing global socioeconomic threat, but there are ways to prevent or mitigate its impact. By adopting a proactive approach to fighting the condition, eye care professionals can identify and help those most at risk before more serious intervention is necessary. The Macular Pigment Screener (MPS II) is a key enabler in such an approach. It helps patients by identifying and monitoring macular pigment levels over time and supports professionals with the diversification of eye health services. It is: Reliable → scientifically validated through use in multiple studies Repeatable → has accurately measured more than 4 million eye Intuitive → easy-to-use user interface with icon-driven menus Fast → screen in 90 seconds per eye for efficient patient care Commercially viable → clear ROI through test fees and supplement sales